Announce Date | 07/17/2025 |
EPS Normalized Actual | $1.66 (Beat by $0.23) |
EPS GAAP Actual | $1.66 (Beat by $0.23) |
Revenue Actual | $11.023B |
Revenue Surprise | Beat by $11023M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.20689 |
EPS GAAP Estimate | $1.20689 |
Revenue Estimate | $9.741461503B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 8.68 | 31.23 | 8.38877 | 9.15254 | 1 |
Dec 2028 | 7.78 | 34.84 | 6.89831 | 8.5708 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.91 | 0.51754 | 11.023B | 17.5% | -7851.81M |
FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 9.935B | -61.58% | 9935M |
FQ4 2024 (Dec 2024) | 1.74 | 1.74 | 10.811B | -79.66% | 10811M |
FQ3 2024 (Sep 2024) | 1.7 | 1.7 | 0.899B | -1829.48% | 899M |
FQ2 2024 (Jun 2024) | 1.15 | 1.15 | 9.094B | -83.63% | 9094M |
FQ1 2024 (Mar 2024) | 1.41 | 1.41 | 16.053B | 9.77% | 16053M |
FQ4 2023 (Dec 2023) | 1.49 | 1.49 | 19.423B | -12.17% | 19423M |
FQ3 2023 (Sep 2023) | 0.24 | 0.24 | 17.346B | -10.02% | 17346M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.20689
Consensus Revenue Estimates
9.741461503B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.00993 | -- | 1.96519 | 2.07319 | 5 |
FQ3 2027 (Sep 2027) | 2.07654 | -- | 2.03032 | 2.14189 | 2 |
FQ2 2027 (Jun 2027) | 1.89 | -- | 1.84793 | 1.94948 | 2 |
FQ1 2027 (Mar 2027) | 1.7553 | -- | 1.71623 | 1.81054 | 2 |
FQ4 2026 (Oct 2026) | 1.63684 | -- | 1.60841 | 1.66603 | 1 |
FQ3 2026 (Jul 2026) | 1.52552 | -- | 1.49903 | 1.55272 | 1 |
FQ2 2026 (Jun 2026) | 1.64496 | -16.11 | 1.60248 | 1.70585 | 5 |
FQ1 2026 (Mar 2026) | 1.30574 | -41.68 | 1.27202 | 1.35407 | 3 |
FQ4 2025 (Oct 2025) | 1.37524 | -26.52 | 1.35136 | 1.39976 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 13.94B | -- | 13.7B | 14.28B | 3 |
FQ3 2027 (Sep 2027) | 12.95B | -- | 12.73B | 13.26B | 3 |
FQ2 2027 (Jun 2027) | 12.02B | -- | 11.82B | 12.31B | 3 |
FQ1 2027 (Mar 2027) | 11.32B | -- | 11.13B | 11.6B | 3 |
FQ4 2026 (Oct 2026) | 11.47B | -- | 11.32B | 11.63B | 2 |
FQ3 2026 (Jul 2026) | 10.93B | -- | 10.79B | 11.08B | 2 |
FQ2 2026 (Jun 2026) | 20.36B | 45.86 | 19.96B | 20.94B | 4 |
FQ1 2026 (Mar 2026) | 18.63B | 46.66 | 18.26B | 19.16B | 4 |
FQ4 2025 (Oct 2025) | 10.42B | -3.74 | 10.28B | 10.56B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.39246 | 1.91 | 0.51754 | 27.1% |
FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 100% | |
FQ4 2024 (Dec 2024) | 1.74 | 1.74 | 100% | |
FQ3 2024 (Sep 2024) | 1.7 | 1.7 | 100% | |
FQ2 2024 (Jun 2024) | 1.15 | 1.15 | 100% | |
FQ1 2024 (Mar 2024) | 1.41 | 1.41 | 100% | |
FQ4 2023 (Dec 2023) | 1.49 | 1.49 | 100% | |
FQ3 2023 (Sep 2023) | 0.24 | 0.24 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $18.87B | $11.02B | $-7851.81M | -71.23% |
FQ1 2025 (Mar 2025) | $0B | $9.94B | $9935M | 100% |
FQ4 2024 (Dec 2024) | $0B | $10.81B | $10811M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.9B | $899M | 100% |
FQ2 2024 (Jun 2024) | $0B | $9.09B | $9094M | 100% |
FQ1 2024 (Mar 2024) | $0B | $16.05B | $16053M | 100% |
FQ4 2023 (Dec 2023) | $0B | $19.42B | $19423M | 100% |
FQ3 2023 (Sep 2023) | $0B | $17.35B | $17346M | 100% |